Deliver Your News to the World

SmallCapNewsRelease:(OTCBB: CBIS) TO Extend its Footprint into California


JERICHO, NY—(SmallCapNewsRelease)—December 14, 2011, Cannabis Science, Inc (OTCBB: CBIS) a biotech company developing pharmaceutical cannabis products, is pleased to announce it has entered final negotiations to bring its Cannabis Science brand of pharmaceutical products into the state of California.
This strategic partnership would allow Cannabis Science to answer the demand for its product by making them available to more than 1.4 million cancer patients in California. This deal also opens access to resources for Cannabis Science in California including laboratories for quality assurance and testing, an educational platform to distribute information about the science of cannabis.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products.
To view the entire press release, please visit
SmallCapNewsRelease gainers are eOn Communications Corp (NASDAQ: EONC) Accelr8 Technology Corp (NYSE: AXK) MER Telemanagement Solutions (NASDAQ: MTSL) Ampio Pharma (NASDAQ: AMPE) Albany Molcular Research (NASDAQ: AMRI) ViroPharma Inc (NASDAQ: VPHM) Lantronix, Inc (NASDAQ: LTRX) Seneca Foods Corp (NASDAQ: SENEB)
SmallCapNewsRelease decliners are Sequans Communications (NASDAQ: SQNS) First Solar (NASDAQ: FSLR) HyperDynamics Corp (NYSE: HDY) Silicon Graphics International (NYSE: SGI) SunPower Corp (NASDAQ: SPWR) BioSante Pharma (NASDAQ: BPAX) Arabian American Development (NASDAQ: ARSD) Adeona Pharma (NYSE: AEN)
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid SmallCapNewsRelease one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation do no trading of any kind and send no Faxes or emails.



This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.